As many as a third of autism cases could be explained by a scarcity of a single protein in the brain, Toronto scientists have revealed. The findings provide a unique opportunity to develop treatments for a disorder that is rooted in a motley crew of genetic faults.
Dec 15 / 2016
Five Donnelly Centre teams have won Genome Canada’s Disruptive Innovation in Genomics grants in support of research projects totalling more than $6 million. The competition was set to boost development of technologies that have a potential to transform and speed up the commercialization of biomedical discovery.
Dec 9 / 2016
The study could pave the way for more meaningful interpretation of personal genomes. Donnelly Centre researchers have discovered that the largest group of human proteins, which work as genome gatekeepers to control gene activity, are even more diverse in their roles than previously thought. The finding expands our understanding of how proteins “read” the DNA and could lead to a more accurate interpretation of individual genomes.
Nov 29 / 2016
Donnelly Researchers Rapidly Identify New Drug Target and Develop Antibodies to Kill Pancreatic Cancer Cells
Researchers at the University of Toronto have developed a process that dramatically cuts the amount of time it takes to create new cancer treatments.
Nov 22 / 2016